BioLife Solutions, Inc.
General ticker "BLFS" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.1B (TTM average)
BioLife Solutions, Inc. follows the US Stock Market performance with the rate: 27.3%.
Estimated limits based on current volatility of 2.9%: low 26.06$, high 27.63$
Factors to consider:
- Total employees count: 159 (-61.6%) as of 2024
- Top business risk factors: Pandemic risks, Product performance, Labor/talent shortage/retention, Manufacturing risks, Litigation risks
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.20$, 31.88$]
- 2026-12-31 to 2027-12-31 estimated range: [20.33$, 32.12$]
Financial Metrics affecting the BLFS estimates:
- Negative: with PPE of -118.6 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
- Positive: -9.55 < Industry operating profit margin (median), % of -3.62
- Positive: -0.02 < Operating cash flow per share per price, % of 1.68
- Positive: Inventory ratio change, % of -2.26 <= -0.75
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of -2.90
- Positive: -14.17 < Investing cash flow per share per price, % of -5.98
Short-term BLFS quotes
Long-term BLFS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $75.86MM | $82.25MM | $96.21MM |
| Operating Expenses | $99.30MM | $89.38MM | $112.82MM |
| Operating Income | $-23.44MM | $-7.13MM | $-16.60MM |
| Non-Operating Income | $4.97MM | $-4.30MM | $4.52MM |
| R&D Expense | $5.51MM | $4.75MM | $23.09MM |
| Income(Loss) | $-18.47MM | $-11.43MM | $-12.08MM |
| Taxes | $0.02MM | $-0.04MM | $0.05MM |
| Other Income(Loss) | $-55.38MM | $-11.13MM | $7.54MM |
| Net Income(Loss)* | $-66.43MM | $-20.18MM | $-4.59MM |
| Stockholders Equity | $337.66MM | $348.91MM | $371.89MM |
| Inventory | $43.46MM | $29.01MM | $30.16MM |
| Assets | $412.71MM | $399.49MM | $405.88MM |
| Operating Cash Flow | $-12.50MM | $8.43MM | $20.11MM |
| Capital expenditure | $6.38MM | $3.23MM | $9.48MM |
| Investing Cash Flow | $17.84MM | $58.30MM | $-71.54MM |
| Financing Cash Flow | $10.59MM | $-6.78MM | $-10.92MM |
| Earnings Per Share** | $-1.52 | $-0.44 | $-0.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.